Minsik Ahn, Ph.D. - Publications

Affiliations: 
2007 Georgia Institute of Technology, Atlanta, GA 
Area:
Electronics and Electrical Engineering

176 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Park S, Ahn MJ. Osimertinib in CNS progressive EGFR-mutant lung cancer: Do we need to detect T790M? Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 32890631 DOI: 10.1016/j.annonc.2020.08.2234  0.4
2020 Lee SH, Ahn MB, Choi YJ, Kim SK, Kim SH, Cho WK, Cho KS, Suh BK, Jung MH. A comparison of different criteria for the definition of insulin resistance and its relationship to metabolic risk in children and adolescents. Annals of Pediatric Endocrinology & Metabolism. PMID 32871651 DOI: 10.6065/apem.2040002.001  0.36
2020 Choi YJ, Lee YJ, Lee NY, Lee SH, Kim SK, Ahn MB, Kim SH, Cho WK, Cho KS, Jung MH, Suh BK. Discriminatory performance of insulin-like growth factor 1 and insulin-like growth factor binding protein-3 levels by correlating values to chronological age, bone age, and pubertal status for the diagnosis of isolated growth hormone deficiency. Annals of Pediatric Endocrinology & Metabolism. PMID 32871649 DOI: 10.6065/apem.2040018.009  0.36
2020 Papadimitrakopoulou VA, Mok TS, Han JY, Ahn MJ, Delmonte A, Ramalingam SS, Kim SW, Shepherd FA, Laskin J, He Y, Akamatsu H, Theelen WSME, Su WC, John T, Sebastian M, et al. Osimertinib versus platinum-pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 32861806 DOI: 10.1016/j.annonc.2020.08.2100  0.44
2020 Park JH, Chun SH, Lee YG, Chang H, Lee KW, Kim HR, Shin SH, An HJ, Lee KE, Hwang IG, Ahn MJ, Kim SB, Keam B. Correction to: Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18-12. Journal of Cancer Research and Clinical Oncology. PMID 32852636 DOI: 10.1007/s00432-020-03342-3  0.44
2020 Ahn MS, Yoo BS, Son JW, Yu MH, Kang DR, Lee HY, Jeon ES, Kim JJ, Chae SC, Baek SH, Kang SM, Choi DJ, Kim KH, Cho MC, Kim SY. Beta-blocker Therapy at Discharge in Patients with Acute Heart Failure and Atrial Fibrillation. Journal of Korean Medical Science. 35: e278. PMID 32830467 DOI: 10.3346/jkms.2020.35.e278  0.6
2020 Hwang J, Ahn M, Choi J, Wee KR. Inter-ligand energy transfer process in an Ir-complex with expanding π-conjugated ligand. Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry. PMID 32812341 DOI: 10.1002/cphc.202000565  0.36
2020 Kim HJ, Koo KA, Park WS, Kang DM, Kim HS, Lee BY, Goo YM, Kim JH, Lee MK, Woo DK, Kwak SS, Ahn MJ. Anti-obesity activity of anthocyanin and carotenoid extracts from color-fleshed sweet potatoes. Journal of Food Biochemistry. e13438. PMID 32812262 DOI: 10.1111/jfbc.13438  0.36
2020 Lee J, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ. Are there any ethnic differences in the efficacy and safety of immune checkpoint inhibitors for treatment of lung cancer? Journal of Thoracic Disease. 12: 3796-3803. PMID 32802459 DOI: 10.21037/jtd.2019.08.29  0.52
2020 Park J, Chun SH, Lee YG, Chang H, Lee KW, Kim HR, Shin SH, An HJ, Lee KE, Hwang IG, Ahn MJ, Kim SB, Keam B. Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18-12. Journal of Cancer Research and Clinical Oncology. PMID 32671504 DOI: 10.1007/s00432-020-03316-5  0.36
2020 Ahn MY, Oh DH, Kim S, Choi JP, Lee JH, Lee YK, Hong KH. Four cases of coronavirus disease 2019 in the early stage of pandemic of South Korea: a single public hospital experience. The Korean Journal of Internal Medicine. 35: 788-792. PMID 32668515 DOI: 10.3904/kjim.2020.079  0.4
2020 Lee J, La Choi Y, Han J, Park S, Jung HA, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ. Osimertinib improves overall survival in EGFR-mutated non-small cell lung cancer patients with leptomeningeal metastases regardless of T790M mutational status. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 32652216 DOI: 10.1016/j.jtho.2020.06.018  0.52
2020 Park S, Shim J, Mortimer PGS, Smith SA, Godin RE, Hollingsworth SJ, Kim HJ, Jung HA, Sun JM, Park WY, Ahn JS, Ahn MJ, Lee SH, Park K. Biomarker-driven phase 2 umbrella trial study for patients with recurrent small cell lung cancer failing platinum-based chemotherapy. Cancer. PMID 32584426 DOI: 10.1002/cncr.33048  0.52
2020 Tae IH, Son JY, Lee SH, Ahn MY, Yoon K, Yoon S, Moon HR, Kim HS. A new SIRT1 inhibitor, MHY2245, induces autophagy and inhibits energy metabolism via PKM2/mTOR pathway in human ovarian cancer cells. International Journal of Biological Sciences. 16: 1901-1916. PMID 32398958 DOI: 10.7150/ijbs.44343  0.36
2020 Ahn MS, Eom YW, Oh JE, Cha SK, Park KS, Son JW, Lee JW, Youn YJ, Ahn SG, Kim JY, Lee SH, Yoon J, Yoo BS. Transient receptor potential channel TRPV4 mediates TGF-β1-induced differentiation of human ventricular fibroblasts. Cardiology Journal. PMID 32329036 DOI: 10.5603/CJ.a2019.0050  0.36
2020 Shim JH, Kim HS, Cha H, Kim S, Kim TM, Anagnostou V, Choi YL, Jung HA, Sun JM, Ahn JS, Ahn MJ, Park K, Park WY, Lee SH. HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L)1 blockade in advanced non-small-cell lung cancer patients. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 32320754 DOI: 10.1016/j.annonc.2020.04.004  0.52
2020 Lim SH, Sun JM, Hong J, Oh D, Ahn YC, Chung MK, Jeong HS, Son YI, Ahn MJ, Baek CH, Park K. Induction chemotherapy followed by concurrent chemoradiotherapy versus CCRT for locally advanced hypopharynx and base of tongue cancer. The Korean Journal of Internal Medicine. PMID 32241084 DOI: 10.3904/kjim.2019.161  0.52
2020 Lee J, Kim HS, Lee B, Kim HK, Sun JM, Ahn JS, Ahn MJ, Park K, Lee SH. Genomic landscape of acquired resistance to third-generation EGFR tyrosine kinase inhibitors in EGFR T790M-mutant non-small cell lung cancer. Cancer. PMID 32154925 DOI: 10.1002/cncr.32809  0.52
2020 Oxnard GR, Yang JC, Yu H, Kim SW, Saka H, Horn L, Goto K, Ohe Y, Mann H, Thress KS, Frigault MM, Vishwanathan K, Ghiorghiu D, Ramalingam SS, Ahn MJ. TATTON: a multi-arm, phase Ib trial of osimertinib combined with selumetinib, savolitinib, or durvalumab in EGFR-mutant lung cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 32139298 DOI: 10.1016/j.annonc.2020.01.013  0.44
2020 Lee JW, Moon JS, Kang DR, Lee SJ, Son JW, Youn YJ, Ahn SG, Ahn MS, Kim JY, Yoo BS, Lee SH, Kim JH, Jung MH, Park JS, Chae SC, et al. Clinical Impact of Atypical Chest Pain and Diabetes Mellitus in Patients with Acute Myocardial Infarction from Prospective KAMIR-NIH Registry. Journal of Clinical Medicine. 9. PMID 32059609 DOI: 10.3390/jcm9020505  0.36
2020 Sequist LV, Han JY, Ahn MJ, Cho BC, Yu H, Kim SW, Yang JC, Lee JS, Su WC, Kowalski D, Orlov S, Cantarini M, Verheijen RB, Mellemgaard A, Ottesen L, et al. Osimertinib plus savolitinib in patients with EGFR mutation-positive, MET-amplified, non-small-cell lung cancer after progression on EGFR tyrosine kinase inhibitors: interim results from a multicentre, open-label, phase 1b study. The Lancet. Oncology. PMID 32027846 DOI: 10.1016/S1470-2045(19)30785-5  0.44
2020 Byeon S, Cho JH, Jung HA, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ. PD-1 inhibitors for non-small cell lung cancer patients with special issues: Real-world evidence. Cancer Medicine. PMID 32027780 DOI: 10.1002/cam4.2868  0.52
2020 Fernando PDSM, Piao MJ, Zhen AX, Ahn MJ, Yi JM, Choi YH, Hyun JW. Extract of Protects Keratinocytes from Particulate Matter-induced Oxidative Stress. International Journal of Medical Sciences. 17: 63-70. PMID 31929739 DOI: 10.7150/ijms.36476  0.32
2020 Shin S, Choi YS, Jung JJ, Im Y, Shin SH, Kang D, Cho JH, Kim HK, Kim J, Zo JI, Shim YM, Park K, Ahn MJ, Ahn YC, Lee G, et al. Impact of diffusing lung capacity before and after neoadjuvant concurrent chemoradiation on postoperative pulmonary complications among patients with stage IIIA/N2 non-small-cell lung cancer. Respiratory Research. 21: 13. PMID 31924201 DOI: 10.1186/s12931-019-1254-0  0.52
2019 Yuk JS, Shin SW, Chun SH, Ku BM, Choi YJ, Lim YT, Luo D, Ahn MJ, Um SH. Topological Transformation-Based Nanobarcoding for Detection and Enumeration of MicroRNAs and Single Nucleotide Polymorphism. Advanced Biosystems. 3: e1900013. PMID 32648670 DOI: 10.1002/adbi.201900013  0.36
2019 Shin HT, Kim NKD, Yun JW, Lee B, Kyung S, Lee KW, Ryu D, Kim J, Bae JS, Park D, Choi YL, Lee SH, Ahn MJ, Park K, Park WY. JuLI: accurate detection of DNA fusions in clinical sequencing for precision oncology. The Journal of Molecular Diagnostics : Jmd. PMID 31881333 DOI: 10.1016/j.jmoldx.2019.10.015  0.52
2019 Byeon S, Lee B, Park WY, Choi YL, Jung HA, Sun JM, Ahn JS, Ahn MJ, Park K, Lee SH. Benefit of Targeted DNA Sequencing in Advanced Non-Small-Cell Lung Cancer Patients Without EGFR and ALK Alterations on Conventional Tests. Clinical Lung Cancer. PMID 31839532 DOI: 10.1016/j.cllc.2019.11.006  0.52
2019 Cho JH, Lim SH, An HJ, Kim KH, Park KU, Kang EJ, Choi YH, Ahn MS, Lee MH, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ. Osimertinib for Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1900931. PMID 31825714 DOI: 10.1200/JCO.19.00931  0.6
2019 Yang JCH, Kim SW, Kim DW, Lee JS, Cho BC, Ahn JS, Lee DH, Kim TM, Goldman JW, Natale RB, Brown AP, Collins B, Chmielecki J, Vishwanathan K, Mendoza-Naranjo A, ... Ahn MJ, et al. Osimertinib in Patients With Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer and Leptomeningeal Metastases: The BLOOM Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1900457. PMID 31809241 DOI: 10.1200/JCO.19.00457  0.52
2019 Hyun SH, Ahn MS, Koh YW, Lee SJ. A Machine-Learning Approach Using PET-Based Radiomics to Predict the Histological Subtypes of Lung Cancer. Clinical Nuclear Medicine. PMID 31693608 DOI: 10.1097/RLU.0000000000002810  0.36
2019 Hyun SH, Ahn MS, Koh YW, Lee SJ. A Machine-Learning Approach Using PET-Based Radiomics to Predict the Histological Subtypes of Lung Cancer. Clinical Nuclear Medicine. 44: 956-960. PMID 31689276 DOI: 10.1097/RLU.0000000000002810  0.36
2019 Das D, Park J, Ahn M, Park S, Hur J, Jeon S. Broad spectral responsivity in highly photoconductive InZnO/MoS heterojunction phototransistor with ultrathin transparent metal electrode. Nanotechnology. 31: 035201. PMID 31626594 DOI: 10.1088/1361-6528/ab4526  0.44
2019 Park J, Das D, Ahn M, Park S, Hur J, Jeon S. Improved optical performance of multi-layer MoS phototransistor with see-through metal electrode. Nano Convergence. 6: 32. PMID 31576481 DOI: 10.1186/s40580-019-0202-5  0.44
2019 Ryu YS, Kang KA, Piao MJ, Ahn MJ, Yi JM, Bossis G, Hyun YM, Park CO, Hyun JW. Particulate matter-induced senescence of skin keratinocytes involves oxidative stress-dependent epigenetic modifications. Experimental & Molecular Medicine. 51: 108. PMID 31551408 DOI: 10.1038/s12276-019-0305-4  0.32
2019 Jung H, Kim HS, Kim JY, Sun JM, Ahn JS, Ahn MJ, Park K, Esteller M, Lee SH, Choi JK. DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load. Nature Communications. 10: 4278. PMID 31537801 DOI: 10.1038/s41467-019-12159-9  0.52
2019 Piao MJ, Kang KA, Zhen AX, Fernando PDSM, Ahn MJ, Koh YS, Kang HK, Yi JM, Choi YH, Hyun JW. Particulate Matter 2.5 Mediates Cutaneous Cellular Injury by Inducing Mitochondria-Associated Endoplasmic Reticulum Stress: Protective Effects of Ginsenoside Rb1. Antioxidants (Basel, Switzerland). 8. PMID 31505827 DOI: 10.3390/antiox8090383  0.32
2019 Kim HS, Cha H, Kim J, Park WY, Choi YL, Sun JM, Ahn JS, Ahn MJ, Park K, Lee SH. Genomic scoring to determine clinical benefit of immunotherapy by targeted sequencing. European Journal of Cancer (Oxford, England : 1990). 120: 65-74. PMID 31493723 DOI: 10.1016/j.ejca.2019.08.001  0.52
2019 Richa S, Dey P, Park C, Yang J, Son JY, Park JH, Lee SH, Ahn MY, Kim IS, Moon HR, Kim HS. A New Histone Deacetylase Inhibitor, MHY4381, Induces Apoptosis via Generation of Reactive Oxygen Species in Human Prostate Cancer Cells. Biomolecules & Therapeutics. PMID 31476841 DOI: 10.4062/biomolther.2019.074  0.44
2019 Moon SH, Sun JM, Ahn JS, Park K, Kim BT, Lee KH, Ahn MJ, Choi JY. Predictive and Prognostic Value of F-fluorodeoxyglucose Uptake Combined with Thymidylate Synthase Expression in Patients with Advanced Non-Small Cell Lung Cancer. Scientific Reports. 9: 12215. PMID 31434972 DOI: 10.1038/s41598-019-48674-4  0.52
2019 Han HH, Ahn MR, Lee JH. Penoscrotal reconstruction with superficial circumflex iliac artery perforator propeller flap. Microsurgery. PMID 31433073 DOI: 10.1002/micr.30506  0.4
2019 Oh C, Tewari A, Kim K, Ulayil SK, Shin C, Ahn M, Jeon S. Comprehensive study of high pressure annealing on the ferroelectric properties of Hf0.5Zr0.5O2 thin films. Nanotechnology. PMID 31426039 DOI: 10.1088/1361-6528/ab3c8f  0.44
2019 Suh YC, Ahn MR, Kim SY, Kim YJ, Lee JH. Superficial inferior epigastric artery-supercharged deep inferior epigastric artery perforator flap-based breast reconstruction for a thin patient: A case report. Microsurgery. PMID 31424589 DOI: 10.1002/micr.30503  0.4
2019 Park HS, Kim YH, Kim JS, Oh YS, Shin DG, Pak HN, Hwang GS, Choi KJ, Oh S, Kim JB, Lee MY, Park HW, Kim DK, Jin ES, Park JS, ... ... Ahn MS, et al. Status of international normalized ratio control and treatment patterns in patients with nonvalvular atrial fibrillation taking vitamin K antagonist with or without antiplatelet therapy: Results from KORAFII registry. Journal of Arrhythmia. 35: 593-601. PMID 31410229 DOI: 10.1002/joa3.12183  0.52
2019 Zhen AX, Hyun YJ, Piao MJ, Fernando PDSM, Kang KA, Ahn MJ, Yi JM, Kang HK, Koh YS, Lee NH, Hyun JW. Eckol Inhibits Particulate Matter 2.5-Induced Skin Keratinocyte Damage via MAPK Signaling Pathway. Marine Drugs. 17. PMID 31357588 DOI: 10.3390/md17080444  0.32
2019 Kim SE, Kim HS, Wang Z, Ke Q, Lee CJ, Park SU, Lim YH, Park WS, Ahn MJ, Kwak SS. A single amino acid change at position 96 (Arg to His) of the sweetpotato Orange protein leads to carotenoid overaccumulation. Plant Cell Reports. PMID 31346717 DOI: 10.1007/s00299-019-02448-4  0.36
2019 Ahn MJ, Han JY, Kim DW, Cho BC, Kang JH, Kim SW, Yang JC, Mitsudomi T, Lee JS. Osimertinib in Patients with T790M Positive Advanced Non-small Cell Lung Cancer: Korean Subgroup Analysis from Phase II Studies. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 31345012 DOI: 10.4143/crt.2019.200  0.44
2019 Lee K, Jung HA, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ. Clinical Characteristics and Outcomes of Non-small Cell Lung Cancer Patients with HER2 Alterations in Korea. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 31345011 DOI: 10.4143/crt.2019.186  0.52
2019 Woo YM, Kim OJ, Jo ES, Kim SJ, Lee YH, Ahn MY, Lee SH, Ha JM, Kim A. Anti-inflammatory effects of the combined extracts of and and . Data in Brief. 25: 104088. PMID 31294054 DOI: 10.1016/j.dib.2019.104088  0.36
2019 Kim CY, Park KH, Ahn J, Ahn MD, Cha SC, Kim HS, Kim JM, Kim MJ, Kim TW, Kim YY, Lee JW, Park SW, Sohn YH, Sung KR, Yoo C, et al. A Path Analysis of Effects of Patients' Underlying Conditions, Treatment Satisfaction and Adherence on Quality of Life among Korea Glaucoma Patients. Journal of Glaucoma. PMID 31233453 DOI: 10.1097/IJG.0000000000001312  0.52
2019 Antonia SJ, Balmanoukian A, Brahmer J, Ou SI, Hellmann MD, Kim SW, Ahn MJ, Kim DW, Gutierrez M, Liu SV, Schöffski P, Jäger D, Jamal R, Jerusalem G, Lutzky J, et al. Clinical Activity, Tolerability, and Long-term Follow-up of Durvalumab in Patients With Advanced NSCLC. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 31228626 DOI: 10.1016/j.jtho.2019.06.010  0.44
2019 Bak SH, Park H, Sohn I, Lee SH, Ahn MJ, Lee HY. Prognostic Impact of Longitudinal Monitoring of Radiomic Features in Patients with Advanced Non-Small Cell Lung Cancer. Scientific Reports. 9: 8730. PMID 31217441 DOI: 10.1038/s41598-019-45117-y  0.36
2019 Kim Y, Kim CH, Lee HY, Lee SH, Kim HS, Lee S, Cha H, Hong S, Kim K, Seo SW, Sun JM, Ahn MJ, Ahn JS, Park K. Comprehensive Clinical and Genetic Characterization of Hyperprogression Based on Volumetry in Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 31195179 DOI: 10.1016/j.jtho.2019.05.033  0.52
2019 Dey P, Kundu A, Sachan R, Park JH, Ahn MY, Yoon K, Lee J, Kim ND, Kim IS, Lee BM, Kim HS. PKM2 Knockdown Induces Autophagic Cell Death via AKT/mTOR Pathway in Human Prostate Cancer Cells. Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology. 52: 1535-1552. PMID 31135122 DOI: 10.33594/000000107  0.52
2019 Park S, Joung JG, Min YW, Nam JY, Ryu D, Oh D, Park WY, Lee SH, Choi Y, Ahn JS, Ahn MJ, Park K, Sun JM. Paired whole exome and transcriptome analyses for the Immunogenomic changes during concurrent chemoradiotherapy in esophageal squamous cell carcinoma. Journal For Immunotherapy of Cancer. 7: 128. PMID 31097034 DOI: 10.1186/s40425-019-0609-x  0.52
2019 Khalil AAK, Park WS, Lee J, Kim HJ, Akter KM, Goo YM, Bae JY, Chun MS, Kim JH, Ahn MJ. A new anti-Helicobacter pylori juglone from Reynoutria japonica. Archives of Pharmacal Research. PMID 31073878 DOI: 10.1007/s12272-019-01160-x  0.52
2019 Lee JW, Oh JE, Rhee KJ, Yoo BS, Eom YW, Park SW, Lee JH, Son JW, Youn YJ, Ahn MS, Ahn SG, Kim JY, Lee SH, Yoon J. Co-treatment with interferon-γ and 1-methyl tryptophan ameliorates cardiac fibrosis through cardiac myofibroblasts apoptosis. Molecular and Cellular Biochemistry. PMID 31006829 DOI: 10.1007/s11010-019-03542-7  0.4
2019 Cho WK, Oh D, Kim HK, Ahn YC, Noh JM, Shim YM, Zo JI, Choi YS, Sun JM, Lee SH, Ahn MJ, Park K, Nam H. Dosimetric predictors for postoperative pulmonary complications in esophageal cancer following neoadjuvant chemoradiotherapy and surgery. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 133: 87-92. PMID 30935586 DOI: 10.1016/j.radonc.2019.01.005  0.52
2019 Cho JH, Jung HA, Lee SH, Ahn JS, Ahn MJ, Park K, Sun JM. Impact of EGFR mutation on the clinical efficacy of PD-1 inhibitors in patients with pulmonary adenocarcinoma. Journal of Cancer Research and Clinical Oncology. PMID 30900155 DOI: 10.1007/s00432-019-02889-0  0.52
2019 Lee K, Kim Y, Jung HA, Lee SH, Ahn JS, Ahn MJ, Park K, Choi YL, Sun JM. Repeat biopsy procedures and T790M rates after afatinib, gefitinib, or erlotinib therapy in patients with lung cancer. Lung Cancer (Amsterdam, Netherlands). 130: 87-92. PMID 30885357 DOI: 10.1016/j.lungcan.2019.01.012  0.52
2019 Lee JY, Sunwoo JS, Kwon KY, Lee KB, Ahn MY, Roh H. Postherpetic Pseudohernia: Lesion Localization using Thoracic Spine Magnetic Resonance Imaging. Journal of Clinical Neurology (Seoul, Korea). PMID 30877702  0.44
2019 Shin SH, Park HY, Im Y, Jung HA, Sun JM, Ahn JS, Ahn MJ, Park K, Lee HY, Lee SH. Improved Treatment Outcome of Pembrolizumab in Patients with Non-small Cell Lung Cancer and Chronic Obstructive Pulmonary Disease. International Journal of Cancer. PMID 30807641 DOI: 10.1002/ijc.32235  0.52
2019 Yi HG, Choi YJ, Jung JW, Jang J, Song TH, Chae S, Ahn M, Choi TH, Rhie JW, Cho DW. Three-dimensional printing of a patient-specific engineered nasal cartilage for augmentative rhinoplasty. Journal of Tissue Engineering. 10: 2041731418824797. PMID 30728937 DOI: 10.1177/2041731418824797  0.44
2019 Zhen AX, Piao MJ, Hyun YJ, Kang KA, Madushan Fernando PDS, Cho SJ, Ahn MJ, Hyun JW. Diphlorethohydroxycarmalol Attenuates Fine Particulate Matter-Induced Subcellular Skin Dysfunction. Marine Drugs. 17. PMID 30717280 DOI: 10.3390/md17020095  0.32
2019 Kim KH, Cho J, Ku BM, Koh J, Sun JM, Lee SH, Ahn JS, Cheon J, Min YJ, Park SH, Park K, Ahn MJ, Shin EC. The first-week proliferative response of peripheral blood PD-1CD8 T cells predicts the response to anti-PD-1 therapy in solid tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30647082 DOI: 10.1158/1078-0432.CCR-18-1449  0.6
2019 Lee JW, Choi E, Khanam SS, Son JW, Youn YJ, Ahn MS, Ahn SG, Kim JY, Lee SH, Yoon J, Yoo BS. Prognostic value of short-term follow-up B-type natriuretic peptide levels after hospital discharge in patients with acute myocardial infarction. International Journal of Cardiology. PMID 30638981 DOI: 10.1016/j.ijcard.2019.01.026  0.36
2019 Yoon HS, Kang JI, Kim SM, Ko A, Koh YS, Hyun JW, Yoon SP, Ahn MJ, Kim YH, Kang JH, Yoo ES, Kang HK. Norgalanthamine Stimulates Proliferation of Dermal Papilla Cells via Anagen-Activating Signaling Pathways. Biological & Pharmaceutical Bulletin. 42: 139-143. PMID 30606985 DOI: 10.1248/bpb.b18-00226  0.32
2018 Nam BD, Kim TJ, Park K, Ahn MJ, Choi YL, Chung MJ, Kim TS, Lee KS. Transthoracic Rebiopsy for Mutation Analysis in Lung Adenocarcinoma: Outcomes and Risk Factors for the Acquisition of Nondiagnostic Specimens in 199 Patients. Clinical Lung Cancer. PMID 30686681 DOI: 10.1016/j.cllc.2018.12.021  0.52
2018 Lee J, Sun JM, Lee SH, Ahn JS, Park K, Choi Y, Ahn MJ. Efficacy and Safety of Lorlatinib in Korean Non-Small-Cell Lung Cancer Patients With ALK or ROS1 Rearrangement Whose Disease Failed to Respond to a Previous Tyrosine Kinase Inhibitor. Clinical Lung Cancer. PMID 30683630 DOI: 10.1016/j.cllc.2018.12.020  0.52
2018 Zhen AX, Piao MJ, Hyun YJ, Kang KA, Ryu YS, Cho SJ, Kang HK, Koh YS, Ahn MJ, Kim TH, Hyun JW. Purpurogallin Protects Keratinocytes from Damage and Apoptosis Induced by Ultraviolet B Radiation and Particulate Matter 2.5. Biomolecules & Therapeutics. PMID 30419635 DOI: 10.4062/biomolther.2018.151  0.32
2018 Park SB, Kwon KY, Lee JY, Im K, Sunwoo JS, Lee KB, Roh H, Ahn MY, Park S, Kim SJ, Oh JS, Kim JS. Lack of association between dopamine transporter loss and non-motor symptoms in patients with Parkinson's disease: a detailed PET analysis of 12 striatal subregions. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. PMID 30415448 DOI: 10.1007/s10072-018-3632-7  0.44
2018 Lee JY, Sunwoo JS, Kwon KY, Roh H, Ahn MY, Lee MH, Park BW, Hyon MS, Lee KB. Left Ventricular Ejection Fraction Predicts Poststroke Cardiovascular Events and Mortality in Patients without Atrial Fibrillation and Coronary Heart Disease. Korean Circulation Journal. 48: 1148-1156. PMID 30403019 DOI: 10.4070/kcj.2018.0115  0.44
2018 Lee YJ, Lee HY, Ahn MB, Kim SK, Cho WK, Lee JW, Chung NG, Cho B, Suh BK. Thyroid dysfunction in children with leukemia over the first year after hematopoietic stem cell transplantation. Journal of Pediatric Endocrinology & Metabolism : Jpem. PMID 30325734 DOI: 10.1515/jpem-2018-0162  0.36
2018 Lee JH, Kim SK, Lee EK, Ahn MB, Kim SH, Cho WK, Cho KS, Jung MH, Suh BK. Factors affecting height velocity in normal prepubertal children. Annals of Pediatric Endocrinology & Metabolism. 23: 148-153. PMID 30286571 DOI: 10.6065/apem.2018.23.3.148  0.4
2018 Park JY, Ryu H, Lee B, Ha DH, Ahn M, Kim S, Kim JY, Jeon NL, Cho DW. Development of a functional airway-on-a-chip by 3D cell printing. Biofabrication. PMID 30270851 DOI: 10.1088/1758-5090/aae545  0.6
2018 Lim SW, Park S, Kim Y, Cho JH, Park SE, Lee H, Kim HK, Kim SM, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ. Continuation of gefitinib beyond progression in patients with EGFR mutation-positive non-small-cell lung cancer: A phase II single-arm trial. Lung Cancer (Amsterdam, Netherlands). 124: 293-297. PMID 30268476 DOI: 10.1016/j.lungcan.2018.08.003  0.52
2018 Park JH, Park JY, Nam IC, Ahn M, Lee JY, Choi SH, Kim SW, Cho DW. A rational tissue engineering strategy based on three-dimensional (3D) printing for extensive circumferential tracheal reconstruction. Biomaterials. 185: 276-283. PMID 30261427 DOI: 10.1016/j.biomaterials.2018.09.031  0.6
2018 Ho TT, Lee JD, Ahn MS, Kim SW, Park SY. Enhanced production of phenolic compounds in hairy root cultures of Polygonum multiflorum and its metabolite discrimination using HPLC and FT-IR methods. Applied Microbiology and Biotechnology. PMID 30218377 DOI: 10.1007/s00253-018-9359-9  0.44
2018 Lee KH, Ahn YC, Pyo H, Noh JM, Park SG, Kim TG, Lee E, Nam H, Lee H, Sun JM, Ahn JS, Ahn MJ, Park K. Salvage Concurrent Chemo-radiation Therapy for Loco-regional Recurrence Following Curative Surgery of Non-small Cell Lung Cancer. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 30205417 DOI: 10.4143/crt.2018.366  0.52
2018 Yoo KH, Lee SJ, Cho J, Lee KH, Park KU, Kim KH, Cho EK, Choi YH, Kim HR, Kim HG, Ahn HJ, Lee HY, Yun HJ, Kang JH, Jeong J, ... ... Ahn MJ, et al. A Randomized, Open-Label, Phase II Study Comparing Pemetrexed Plus Cisplatin Followed by Maintenance Pemetrexed versus Pemetrexed Alone in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Non-small Cell Lung Cancer after Failure of First-Line EGFR Tyrosine Kinase Inhibitor: KCSG-LU12-13. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 30177585 DOI: 10.4143/crt.2018.324  0.6
2018 Moon SH, Kim J, Joung JG, Cha H, Park WY, Ahn JS, Ahn MJ, Park K, Choi JY, Lee KH, Kim BT, Lee SH. Correlations between metabolic texture features, genetic heterogeneity, and mutation burden in patients with lung cancer. European Journal of Nuclear Medicine and Molecular Imaging. PMID 30145701 DOI: 10.1007/s00259-018-4138-5  0.52
2018 Choi IJ, Kang A, Ahn MH, Jun H, Baek SK, Park JH, Na W, Choi SO. Insertion-responsive microneedles for rapid intradermal delivery of canine influenza vaccine. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 30102940 DOI: 10.1016/j.jconrel.2018.08.017  0.44
2018 Byeon S, Kim Y, Lim SW, Cho JH, Park S, Lee J, Sun JM, Choi YL, Lee SH, Ahn JS, Park K, Ahn MJ. Clinical Outcomes of EGFR Exon 20 Insertion Mutations in Advanced Non-small Cell Lung Cancer in Korea. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 30049203 DOI: 10.4143/crt.2018.151  0.52
2018 Song JE, Ahn MY, Kim WJ, Kim SW, Lee JS, Ku NS, Kim JH, Kim KH, Ann H, Choi JY. Prevalence of CCR5 tropism among HIV-1-infected patients in South Korea. Journal of Medical Virology. PMID 29981165 DOI: 10.1002/jmv.25254  0.6
2018 Kim MJ, Kim SM, Jung HA, Hong JY, Chang WJ, Choi MK, Kim HS, Sun JM, Park K, Ahn MJ. Efficacy and safety of cisplatin and weekly docetaxel in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. The Korean Journal of Internal Medicine. PMID 29914230 DOI: 10.3904/kjim.2017.234  0.52
2018 Lee SW, Park H, Lee HY, Sohn I, Lee SH, Kang J, Sun JM, Ahn MJ. Deciphering Clinicoradiologic Phenotype for Thymidylate Synthase Expression Status in Patients with Advanced Lung Adenocarcinoma Using a Radiomics Approach. Scientific Reports. 8: 8968. PMID 29895834 DOI: 10.1038/s41598-018-27273-9  0.36
2018 Park S, Ahn BC, Lim SW, Sun JM, Kim HR, Hong MH, Lee SH, Ahn JS, Park K, Choi Y, Cho BC, Ahn MJ. Characteristics and outcome of ROS1-Positive Non-Small Cell Lung Cancer Patients in Routine Clinical Practice. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 29883837 DOI: 10.1016/j.jtho.2018.05.026  0.52
2018 Lee J, Shim JH, Park WY, Kim HK, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ. Rare Mechanism of Acquired Resistance to Osimertinib in Korean Patients with EGFR-mutated Non-small Cell Lung Cancer. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 29807405 DOI: 10.4143/crt.2018.138  0.52
2018 Lee H, Lee HY, Sun JM, Lee SH, Kim Y, Park SE, Ahn JS, Park K, Ahn MJ. Transient asymptomatic pulmonary opacities during osimertinib treatment and its clinical implication. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 29775809 DOI: 10.1016/j.jtho.2018.04.038  0.52
2018 Lim SM, Cho SH, Hwang IG, Choi JW, Chang H, Ahn MJ, Park KU, Kim JW, Ko YH, Ahn HK, Cho BC, Nam BH, Chun SH, Hong JH, Kwon JH, et al. Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 29747488 DOI: 10.4143/crt.2018.012  0.32
2018 Park JY, Ahn MK, Cho EB, Park EJ, Kim KH. Dual-Frequency Ultrasound as a New Treatment Modality for Refractory Rosacea: A Retrospective Study. Dermatologic Surgery : Official Publication For American Society For Dermatologic Surgery [Et Al.]. PMID 29746429 DOI: 10.1097/DSS.0000000000001552  0.6
2018 Park S, Lee HB, Lee JK, Park YM, Lee T, Park Y, Ahn MH, Hong JP. Associations between the brain-derived neurotrophic factor Val66Met polymorphisms and suicide in patients with cancer. Psychiatric Genetics. PMID 29734216 DOI: 10.1097/YPG.0000000000000199  0.4
2018 Piao MJ, Ahn MJ, Kang KA, Ryu YS, Hyun YJ, Shilnikova K, Zhen AX, Jeong JW, Choi YH, Kang HK, Koh YS, Hyun JW. Particulate matter 2.5 damages skin cells by inducing oxidative stress, subcellular organelle dysfunction, and apoptosis. Archives of Toxicology. PMID 29582092 DOI: 10.1007/s00204-018-2197-9  0.32
2018 Kim JS, Son JY, Kim KS, Lim HJ, Ahn MY, Kwack SJ, Kim YM, Lee KY, Lee J, Lee BM, Kim HS. Hepatic damage exacerbates cisplatin-induced acute kidney injury in Sprague-Dawley rats. Journal of Toxicology and Environmental Health. Part A. 1-11. PMID 29557720 DOI: 10.1080/15287394.2018.1451179  0.52
2018 Lee J, Kim ST, Park S, Lee S, Park SH, Park JO, Lim HY, Ahn H, Bok H, Kim KM, Ahn MJ, Kang WK, Park YS. Phase I Trial of Anti-MET Monoclonal Antibody in MET-Overexpressed Refractory Cancer. Clinical Colorectal Cancer. PMID 29551559 DOI: 10.1016/j.clcc.2018.01.005  0.52
2018 Aslamy A, Oh E, Ahn M, Moin ASM, Chang M, Duncan M, Hacker-Stratton J, El-Shahawy M, Kandeel F, DiMeglio LA, Thurmond DC. Exocytosis Protein DOC2B as a Biomarker of Type 1 Diabetes. The Journal of Clinical Endocrinology and Metabolism. PMID 29506054 DOI: 10.1210/jc.2017-02492  0.32
2018 Park BJ, Cho JH, Lee JH, Shin S, Kim HK, Choi YS, Zo JI, Shim YM, Sun JM, Lee SH, Ahn JS, Ahn MJ, Park K, Kim J. Temporal and regional distribution of initial recurrence site in completely resected N1-stage II lung adenocarcinoma: The effect of postoperative adjuvant chemotherapy. Lung Cancer (Amsterdam, Netherlands). 117: 7-13. PMID 29496256 DOI: 10.1016/j.lungcan.2018.01.004  0.52
2018 Cho JH, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ. Late-Onset Cholecystitis with Cholangitis after Avelumab Treatment in Non-Small Cell Lung Cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 13: e34-e36. PMID 29472055 DOI: 10.1016/j.jtho.2017.10.007  0.52
2018 Sun JM, Lee KH, Kim BS, Kim HG, Min YJ, Yi SY, Yun HJ, Jung SH, Lee SH, Ahn JS, Park K, Ahn MJ. Pazopanib maintenance after first-line etoposide and platinum chemotherapy in patients with extensive disease small-cell lung cancer: a multicentre, randomised, placebo-controlled Phase II study (KCSG-LU12-07). British Journal of Cancer. PMID 29381690 DOI: 10.1038/bjc.2017.465  0.52
2018 Tan EH, Lim WT, Ahn MJ, Ng QS, Ahn JS, Shao-Weng Tan D, Sun JM, Han M, Payumo FC, McKee K, Yin W, Credi M, Agarwal S, Jac J, Park K. Phase 1b Trial of Ficlatuzumab, a Humanized Hepatocyte Growth Factor Inhibitory Monoclonal Antibody, in Combination With Gefitinib in Asian Patients With NSCLC. Clinical Pharmacology in Drug Development. PMID 29346833 DOI: 10.1002/cpdd.427  0.52
2018 Lee J, Kim HK, Park BJ, Cho JH, Choi YS, Zo JI, Shim YM, Pyo H, Ahn YC, Ahn JS, Ahn MJ, Park K, Kim J. Recurrence dynamics after trimodality therapy (Neoadjuvant concurrent chemoradiotherapy and surgery) in patients with stage IIIA (N2) lung cancer. Lung Cancer (Amsterdam, Netherlands). 115: 89-96. PMID 29290268 DOI: 10.1016/j.lungcan.2017.11.020  0.52
2017 Ahn MJ, Kim MC, Ahn Y, Sim DS, Hong YJ, Kim JH, Jeong MH, Cho JG, Park JC. Impact of Complete Revascularization on Six-Year Clinical Outcomes and Incidence of Acute Decompensated Heart Failure in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease. The American Journal of Cardiology. PMID 29325904 DOI: 10.1016/j.amjcard.2017.11.025  0.36
2017 Ahn M, Park EJ, Woo JM. Current status and future prospects of research and development operations in traditional and complementary and alternative medicine manufacturing small- and medium-sized enterprises: a 2014 company-based survey. Integrative Medicine Research. 6: 409-417. PMID 29296568 DOI: 10.1016/j.imr.2017.08.006  0.6
2017 Shin HT, Choi YL, Yun JW, Kim NKD, Kim SY, Jeon HJ, Nam JY, Lee C, Ryu D, Kim SC, Park K, Lee E, Bae JS, Son DS, Joung JG, ... ... Ahn MJ, et al. Prevalence and detection of low-allele-fraction variants in clinical cancer samples. Nature Communications. 8: 1377. PMID 29123093 DOI: 10.1038/s41467-017-01470-y  0.52
2017 Cho JH, Ku BM, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ. KIF5B-MET gene rearrangement with robust anti-tumor activity in response to crizotinib in lung adenocarcinoma. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 29102694 DOI: 10.1016/j.jtho.2017.10.014  0.52
2017 Park SE, Lee SH, Ahn JS, Ahn MJ, Park K, Sun JM. Increased Response Rates to Salvage Chemotherapy Administered after PD-1/PD-L1 Inhibitors in Patients with Non-Small Cell Lung Cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 29101058 DOI: 10.1016/j.jtho.2017.10.011  0.52
2017 Ahn MJ, Kim DW, Cho BC, Kim SW, Lee JS, Ahn JS, Kim TM, Lin CC, Kim HR, John T, Kao S, Goldman JW, Su WC, Natale R, Rabbie S, et al. Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study. The Lancet. Respiratory Medicine. PMID 29056570 DOI: 10.1016/S2213-2600(17)30378-8  0.52
2017 Shin SW, Lee BS, Yang K, Amornkitbamrung L, Jang MS, Ku BM, Cho SW, Lee JH, Bae H, Oh BK, Ahn MJ, Lim YT, Um SH. Fluorescence-coded DNA Nanostructure Probe System to Enable Discrimination of Tumor Heterogeneity via a Screening of Dual Intracellular microRNA Signatures in situ. Scientific Reports. 7: 13499. PMID 29044199 DOI: 10.1038/s41598-017-13456-3  0.4
2017 Ku BM, Bae YH, Koh J, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ. Mutational status of TP53 defines the efficacy of Wee1 inhibitor AZD1775 in KRAS-mutant non-small cell lung cancer. Oncotarget. 8: 67526-67537. PMID 28978051 DOI: 10.18632/oncotarget.18728  0.52
2017 Mok TSK, Kim SW, Wu YL, Nakagawa K, Yang JJ, Ahn MJ, Wang J, Yang JC, Lu Y, Atagi S, Ponce S, Shi X, Rukazenkov Y, Haddad V, Thress KS, et al. Gefitinib Plus Chemotherapy Versus Chemotherapy in Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer Resistant to First-Line Gefitinib (IMPRESS): Overall Survival and Biomarker Analyses. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017739250. PMID 28968167 DOI: 10.1200/JCO.2017.73.9250  0.44
2017 Sun JM, Noh JM, Oh D, Kim HK, Lee SH, Choi YS, Pyo H, Ahn JS, Jung SH, Chan Ahn Y, Kim J, Ahn MJ, Zo JI, Shim YM, Park K. Randomized Phase II Trial Comparing Chemoradiotherapy with Chemotherapy for Completely Resected Unsuspected N2-Positive Non-Small Cell Lung Cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 28962948 DOI: 10.1016/j.jtho.2017.09.1954  0.52
2017 Youn YJ, Yoo BS, Son JW, Lee JW, Ahn MS, Ahn SG, Kim JY, Lee SH, Yoon J, Eom YW, Oh JE, Choi SK. Remote Ischemic Conditioning by Effluent Collected from a Novel Isolated Hindlimb Model Reduces Infarct Size in an Isolated Heart Model. Korean Circulation Journal. 47: 714-726. PMID 28955390 DOI: 10.4070/kcj.2017.0092  0.36
2017 Ahn MY, Hwang JS, Lee SB, Ham SA, Hur J, Kim JT, Seo HG. Curcumin longa extract-loaded nanoemulsion improves the survival of endotoxemic mice by inhibiting nitric oxide-dependent HMGB1 release. Peerj. 5: e3808. PMID 28929026 DOI: 10.7717/peerj.3808  0.36
2017 Kim KC, Hyun YJ, Hewage SRKM, Piao MJ, Kang KA, Kang HK, Koh YS, Ahn MJ, Hyun JW. 3-Bromo-4,5-dihydroxybenzaldehyde Enhances the Level of Reduced Glutathione via the Nrf2-Mediated Pathway in Human Keratinocytes. Marine Drugs. 15. PMID 28926995 DOI: 10.3390/md15090291  0.32
2017 Kim HR, Jang JS, Sun JM, Ahn MJ, Kim DW, Jung I, Lee KH, Kim JH, Lee DH, Kim SW, Cho BC. Correction: A randomized, phase II study of gefitinib alone versus nimotuzumab plus gefitinib after platinum-based chemotherapy in advanced non-small cell lung cancer (KCSG LU12-01). Oncotarget. 8: 55766. PMID 28903459 DOI: 10.18632/oncotarget.20268  0.44
2017 Kim SW, Ehrman J, Ahn MR, Kondo J, Lopez AAM, Oh YS, Kim HX, Crawley SW, Goldenring JR, Tyska MJ, Rericha EC, Lau KS. Shear stress induces non-canonical autophagic flux in intestinal epithelial monolayers. Molecular Biology of the Cell. PMID 28855375 DOI: 10.1091/mbc.E17-01-0021  0.44
2017 Piao MJ, Kang KA, Ryu YS, Shilnikova K, Park JE, Hyun YJ, Zhen AX, Kang HK, Koh YS, Ahn MJ, Hyun JW. The Red Algae Compound 3-Bromo-4,5-dihydroxybenzaldehyde Protects Human Keratinocytes on Oxidative Stress-Related Molecules and Pathways Activated by UVB Irradiation. Marine Drugs. 15. PMID 28841171 DOI: 10.3390/md15090268  0.32
2017 Ku BM, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ. An update on biomarkers for kinase inhibitor response in non-small-cell lung cancer. Expert Review of Molecular Diagnostics. PMID 28838271 DOI: 10.1080/14737159.2017.1372196  0.52
2017 Choi N, Lee JY, Sunwoo JS, Roh H, Ahn MY, Park ST, Lee KB. Recently Uncontrolled Glycemia in Diabetic Patients Is Associated with the Severity of Intracranial Atherosclerosis. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. PMID 28784278 DOI: 10.1016/j.jstrokecerebrovasdis.2017.06.025  0.44
2017 Hwang SH, Ahn MR, Han KD, Lee JH. The Prevalence of "Drinking and Biking" and Associated Risk Factors: The Korea National Health and Nutrition Examination Survey. Journal of Korean Medical Science. 32: 1396-1400. PMID 28776333 DOI: 10.3346/jkms.2017.32.9.1396  0.4
2017 Khanam SS, Son JW, Lee JW, Youn YJ, Yoon J, Lee SH, Kim JY, Ahn SG, Ahn MS, Yoo BS. Prognostic value of short-term follow-up BNP in hospitalized patients with heart failure. Bmc Cardiovascular Disorders. 17: 215. PMID 28774268 DOI: 10.1186/s12872-017-0632-0  0.36
2017 Kim HK, Heo MH, Lee HS, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ. Comparison of RECIST to immune-related response criteria in patients with non-small cell lung cancer treated with immune-checkpoint inhibitors. Cancer Chemotherapy and Pharmacology. PMID 28733892 DOI: 10.1007/s00280-017-3396-4  0.52
2017 Ahn MY, Hwang JS, Ham SA, Hur J, Jo Y, Lee S, Choi MJ, Han SG, Seo HG. Subcritical water-hydrolyzed fish collagen ameliorates survival of endotoxemic mice by inhibiting HMGB1 release in a HO-1-dependent manner. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 93: 923-930. PMID 28715873 DOI: 10.1016/j.biopha.2017.07.041  0.36
2017 Seo M, Lee JH, Baek M, Kim MA, Ahn MY, Kim SH, Yun EY, Hwang JS. A novel role for earthworm peptide Lumbricusin as a regulator of neuroinflammation. Biochemical and Biophysical Research Communications. PMID 28666870 DOI: 10.1016/j.bbrc.2017.06.154  0.4
2017 Kim KS, Yang HY, Song H, Kang YR, Kwon J, An J, Son JY, Kwack SJ, Kim YM, Bae ON, Ahn MY, Lee J, Yoon S, Lee BM, Kim HS. Identification of a sensitive urinary biomarker, selenium-binding protein 1, for early detection of acute kidney injury. Journal of Toxicology and Environmental Health. Part A. 1-12. PMID 28665768 DOI: 10.1080/15287394.2017.1299655  0.52
2017 Cho M, Ahn S, Hong M, Bang H, Van Vrancken M, Kim S, Lee J, Park SH, Park JO, Park YS, Lim HY, Kang WK, Sun JM, Lee SH, Ahn MJ, et al. Tissue recommendations for precision cancer therapy using next generation sequencing: a comprehensive single cancer center's experiences. Oncotarget. PMID 28477007 DOI: 10.18632/oncotarget.17199  0.52
2017 Kim DW, Tiseo M, Ahn MJ, Reckamp KL, Hansen KH, Kim SW, Huber RM, West HL, Groen HJM, Hochmair MJ, Leighl NB, Gettinger SN, Langer CJ, Paz-Ares Rodríguez LG, Smit EF, et al. Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016715904. PMID 28475456 DOI: 10.1200/JCO.2016.71.5904  0.44
2017 Soh SX, Siddiqui FJ, Allen JC, Kim GW, Lee JC, Yatabe Y, Soda M, Mano H, Soo RA, Chin TM, Ebi H, Yano S, Matsuo K, Niu X, Lu S, ... ... Ahn MJ, et al. A systematic review and meta-analysis of individual patient data on the impact of the BIM deletion polymorphism on treatment outcomes in epidermal growth factor receptor mutant lung cancer. Oncotarget. PMID 28467813 DOI: 10.18632/oncotarget.17102  0.44
2017 Jeong K, Park S, Park D, Ahn M, Han J, Yang W, Jeong HS, Cho MH. Evolution of crystal structures in GeTe during phase transition. Scientific Reports. 7: 955. PMID 28424509 DOI: 10.1038/s41598-017-01154-z  0.4
2017 Lim SH, Yoh KA, Lee JS, Ahn MJ, Kim YJ, Kim SH, Zhang J, Patel D, Swallow E, Kageleiry A, Galebach P, Lee D, Stein K, Degun R, Park K. Characteristics and outcomes of ALK+ non-small cell lung cancer patients in Korea. Asia-Pacific Journal of Clinical Oncology. PMID 28419723 DOI: 10.1111/ajco.12645  0.52
2017 Lee SJ, Lee SY, Lee WS, Yoo JS, Sun JM, Lee J, Park SH, Park JO, Ahn MJ, Lim HY, Kang WK, Park YS. Phase I trial and pharmacokinetic study of tanibirumab, a fully human monoclonal antibody to vascular endothelial growth factor receptor 2, in patients with refractory solid tumors. Investigational New Drugs. PMID 28391576 DOI: 10.1007/s10637-017-0463-y  0.52
2017 Kim SM, Tripathy DR, Park SW, Park B, Son JW, Lee JW, Youn YJ, Ahn SG, Ahn MS, Kim JY, Yoo BS, Lee SH, Yoon J. Impact of Chronic Kidney Disease on Clinical Outcomes in Diabetic Patients Undergoing Percutaneous Coronary Intervention in the Era of Newer-Generation Drug-Eluting Stents. Korean Circulation Journal. 47: 222-230. PMID 28382078 DOI: 10.4070/kcj.2016.0312  0.36
2017 Ahn MY, Wertheim JO, Kim WJ, Kim SW, Lee JS, Ann HW, Jeon Y, Ahn JY, Song JE, Oh DH, Kim YC, Kim EJ, Jung IY, Kim MH, Jeong W, et al. HIV-1 Transmission Networks Across South Korea. Aids Research and Human Retroviruses. PMID 28346838 DOI: 10.1089/aid.2016.0212  0.44
2017 Ahn MJ, Sun JM, Lee SH, Ahn JS, Park K. EGFR TKI combination with immunotherapy in non-small cell lung cancer. Expert Opinion On Drug Safety. 1-5. PMID 28271729 DOI: 10.1080/14740338.2017.1300656  0.52
2017 Yang JC, Ahn MJ, Kim DW, Ramalingam SS, Sequist LV, Su WC, Kim SW, Kim JH, Planchard D, Felip E, Blackhall F, Haggstrom D, Yoh K, Novello S, Gold K, et al. Osimertinib in Pretreated T790M-Positive Advanced Non-Small-Cell Lung Cancer: AURA Study Phase II Extension Component. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016703223. PMID 28221867 DOI: 10.1200/JCO.2016.70.3223  0.44
2017 Drilon A, Siena S, Ou SI, Patel M, Ahn MJ, Lee J, Bauer TM, Farago AF, Wheler JJ, Liu SV, Doebele R, Giannetta L, Cerea G, Marrapese G, Schirru M, et al. Safety and Antitumor Activity of the Multi-Targeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib (RXDX-101): Combined Results from Two Phase 1 Trials (ALKA-372-001 and STARTRK-1). Cancer Discovery. PMID 28183697 DOI: 10.1158/2159-8290.CD-16-1237  0.52
2017 Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ. Osimertinib for the Treatment of Non-small Cell Lung Cancer. Expert Opinion On Pharmacotherapy. PMID 28116908 DOI: 10.1080/14656566.2017.1285283  0.52
2017 Park K, Cho EK, Bello M, Ahn MJ, Thongprasert S, Song EK, Soldatenkova V, Depenbrock H, Puri T, Orlando M. Efficacy and Safety of First-Line Necitumumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin In East Asian Patients with Stage IV Squamous Non-Small Cell Lung Cancer: A Subgroup Analysis of the Phase 3, Open-Label, Randomized SQUIRE Study. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 28111429 DOI: 10.4143/crt.2016.423  0.52
2017 Kim Y, Lee SJ, Lee JY, Lee SH, Sun JM, Park K, An HJ, Cho JY, Kang EJ, Lee HY, Kim J, Keam B, Kim HR, Lee KE, Choi MY, ... ... Ahn MJ, et al. Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01). Cancer. PMID 28102887 DOI: 10.1002/cncr.30537  0.52
2016 Cha YK, Lee HY, Ahn MJ, Park K, Ahn JS, Sun JM, Choi YL, Lee KS. The impact of smoking status on radiologic tumor progression patterns and response to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors in lung adenocarcinoma with activating EGFR mutations. Journal of Thoracic Disease. 8: 3175-3186. PMID 28066597 DOI: 10.21037/jtd.2016.11.25  0.52
2016 Park H, Oh D, Ahn YC, Pyo H, Noh JM, Sun JM, Ahn JS, Ahn MJ, Park K, Kim HK, Choi YS, Kim J, Zo JI, Shim YM. Role of Adjuvant Thoracic Radiation Therapy and Full Dose Chemotherapy in pN2 Non-Small Cell Lung Cancer: Elucidation Based on Single Institute Experience. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 28052657 DOI: 10.4143/crt.2016.442  0.52
2016 Lee MY, Ku BM, Kim HS, Lee JY, Lim SH, Sun JM, Lee SH, Park K, Oh YL, Hong M, Jeong HS, Son YI, Baek CH, Ahn MJ. Genetic Alterations and Their Clinical Implications in High-Recurrence Risk Papillary Thyroid Cancer. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 28052655 DOI: 10.4143/crt.2016.424  0.52
2016 Moon JJ, Ahn MW, Ahn HS, Lee SJ, Lee DY. Usefulness of K-Point Injection for the Nonspecific Neck Pain in So-Called K-Point Syndrome. Clinics in Orthopedic Surgery. 8: 393-398. PMID 27904721 DOI: 10.4055/cios.2016.8.4.393  0.36
2016 Lee SJ, Sung JH, Kim JB, Ahn MS, Lee HY, Uhm JS, Pak HN, Lee MH, Kim JY, Joung B. The safety and efficacy of vitamin K antagonist in atrial fibrillation patients with previous ulcer bleeding: Long-term results from a multicenter study. Medicine. 95: e5467. PMID 27893694 DOI: 10.1097/MD.0000000000005467  0.36
2016 Ahn MJ, Sun JM, Lee SH, Ahn JS, Park K. Transient Asymptomatic Pulmonary Opacities during Osimertinib Treatment: "Stop or Go" Decision. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 11: 2051-2052. PMID 27866634 DOI: 10.1016/j.jtho.2016.09.130  0.52
2016 Lim SH, Shim YM, Park SH, Kim HK, Choi YS, Ahn MJ, Park K, Zo JI, Sun JM. A Randomized Phase II Study of Leucovorin/5-Fluorouracil with or Without Oxaliplatin (LV5FU2 vs. FOLFOX) for Curatively-Resected, Node-Positive Esophageal Squamous Cell Carcinoma. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 27857024 DOI: 10.4143/crt.2016.417  0.52
2016 Kim HR, Jang JS, Sun JM, Ahn MJ, Kim DW, Jung I, Lee KH, Kim JH, Lee DH, Kim SW, Cho BC. A randomized, phase II study of gefitinib alone versus nimotuzumab plus gefitinib after platinum-based chemotherapy in advanced non-small cell lung cancer (KCSG LU12-01). Oncotarget. PMID 27823977 DOI: 10.18632/oncotarget.13056  0.44
2016 Lee SH, Lee JK, Ahn MJ, Kim DW, Sun JM, Keam B, Kim TM, Heo DS, Ahn JS, Choi YL, Min HS, Jeon YK, Park K. Vandetanib in Pretreated Patients with Advanced Non-Small Cell Lung Cancer Harboring RET Rearrangement: A Phase II Clinical Trial. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 27803005 DOI: 10.1093/annonc/mdw559  0.52
2016 Lee JH, Kim IW, Kim MA, Ahn MY, Yun EY, Hwang JS. Antimicrobial activity of the scolopendrasin V peptide identified from the centipede, Scolopendra subspinipes mutilans. Journal of Microbiology and Biotechnology. PMID 27780954 DOI: 10.4014/jmb.1609.09057  0.4
2016 Hong SK, Park S, Ahn MH, Min BK. Top-down and bottom-up neurodynamic evidence in patients with tinnitus. Hearing Research. PMID 27725178 DOI: 10.1016/j.heares.2016.10.002  0.4
2016 Ahn M, Gunasekaran P, Rajasekaran G, Kim EY, Lee SJ, Bang G, Cho K, Hyun JK, Lee HJ, Jeon YH, Kim NH, Ryu EK, Shin SY, Bang JK. Pyrazole derived ultra-short antimicrobial peptidomimetics with potent anti-biofilm activity. European Journal of Medicinal Chemistry. 125: 551-564. PMID 27718471 DOI: 10.1016/j.ejmech.2016.09.071  0.36
2016 Son JW, Sung JK, Lee JW, Youn YJ, Ahn MS, Ahn SG, Yoo BS, Lee SH, Yoon J, Koh SB, Kim JY. Abdominal obesity and structure and function of the heart in healthy male Koreans: The ARIRANG study. Medicine. 95: e4930. PMID 27684832 DOI: 10.1097/MD.0000000000004930  0.36
2016 Cho WK, Oh D, Ahn YC, Shim YM, Zo JI, Sun JM, Ahn MJ, Park K. Supraclavicular and/or celiac lymph node metastases from thoracic esophageal squamous cell carcinoma did not compromise survival following neoadjuvant chemoradiotherapy and surgery. Oncotarget. PMID 27682879 DOI: 10.18632/oncotarget.12200  0.52
2016 Lee T, Lee HB, Ahn MH, Kim J, Kim MS, Chung SJ, Hong JP. Increased suicide risk and clinical correlates of suicide among patients with Parkinson's disease. Parkinsonism & Related Disorders. PMID 27637284 DOI: 10.1016/j.parkreldis.2016.09.006  0.4
2016 Choi JW, Kong DS, Seol HJ, Nam DH, Yoo KH, Sun JM, Ahn JS, Ahn MJ, Park K, Lee JI. Outcomes of gamma knife radiosurgery in combination with crizotinib for patients with brain metastasis from non-small cell lung cancer. World Neurosurgery. PMID 27565474 DOI: 10.1016/j.wneu.2016.08.046  0.32
2016 Kim BS, Jang J, Chae S, Gao G, Kong JS, Ahn M, Cho DW. Three-dimensional bioprinting of cell-laden constructs with polycaprolactone protective layers for using various thermoplastic polymers. Biofabrication. 8: 035013. PMID 27550946 DOI: 10.1088/1758-5090/8/3/035013  0.44
2016 Byeon S, Ham JS, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ. Analysis of the benefit of sequential cranial radiotherapy in patients with EGFR mutant non-small cell lung cancer and brain metastasis. Medical Oncology (Northwood, London, England). 33: 97. PMID 27447711 DOI: 10.1007/s12032-016-0811-3  0.32
2016 Kim H, Chan Ahn Y, Pyo H, Oh D, Noh JM, Sun JM, Ahn JS, Ahn MJ, Park K, Choi YS, Kim J, Zo JI, Shim YM, Lee M, Han J. Do new pN sub-classifications, proposed by IASLC's lung cancer staging project, agree with ypN categories following tri-modality therapy for initial N2 disease? Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 27423392 DOI: 10.1016/j.jtho.2016.07.005  0.52
2016 Yim CH, Ko JH, Lee JH, Choi YM, Lee WW, Ahn SK, Ahn MH, Choi KE. A Pediatric Case of Thelaziasis in Korea. The Korean Journal of Parasitology. 54: 319-21. PMID 27417087 DOI: 10.3347/kjp.2016.54.3.319  0.4
2016 Park S, Hong JP, Lee JK, Park YM, Park Y, Jeon J, Ahn MH, Yoon SC. Associations between the neuron-specific glucocorticoid receptor (NR3C1) Bcl-1 polymorphisms and suicide in cancer patients within the first year of diagnosis. Behavioral and Brain Functions : Bbf. 12: 22. PMID 27401254 DOI: 10.1186/s12993-016-0104-1  0.36
2016 Bae HS, Kim HJ, Jeong da H, Hosoya T, Kumazawa S, Jun M, Kim OY, Kim SW, Ahn MR. In Vitro and In Vivo Antiangiogenic Activity of Crowberry (Empetrum nigrum var. japonicum). Natural Product Communications. 11: 503-6. PMID 27396205  0.44
2016 Lim SH, Sun JM, Choi YL, Kim HR, Ahn S, Lee JY, Lee SH, Ahn JS, Park K, Kim JH, Cho BC, Ahn MJ. Efficacy and safety of dovitinib in pretreated patients with advanced squamous non-small cell lung cancer with FGFR1 amplification: A single-arm, phase 2 study. Cancer. PMID 27315356 DOI: 10.1002/cncr.30135  0.32
2016 Ahn MJ, Yang J, Yu H, Saka H, Ramalingam S, Goto K, Kim SW, Yang L, Walding A, Oxnard GR. 136O: Osimertinib combined with durvalumab in EGFR-mutant non-small cell lung cancer: Results from the TATTON phase Ib trial. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 11: S115. PMID 27198274 DOI: 10.1016/S1556-0864(16)30246-5  0.44
2015 Kim D, Ahn M, Jung J, Kwon S, Park EJ, Koo KH, Woo JM. Perspectives on the Market Globalization of Korean Herbal Manufacturers: A Company-Based Survey Evidence-Based Complementary and Alternative Medicine. 2015. DOI: 10.1155/2015/515328  0.6
2014 Baek JH, Min YJ, Cho EK, Cho B, Kim J, Sun J, Ahn M, Park K. 1275PEFFICACY OF EGFR TYROSINE KINASE INHIBITORS (EGFR TKIS) IN PATIENTS WITH EGFR-MUTATED NON-SMALL CELL LUNG CANCER EXCEPT BOTH EXON 19 DELETION AND EXON 21 L858R: A RETROSPECTIVE ANALYSIS IN KOREA. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 25: iv448-iv449. PMID 28172362 DOI: 10.1093/annonc/mdu349.54  0.52
2014 Park K, Ahn M, Yu C, Kim S, Lin M, Sriuranpong V, Tsai C, Lee J, Kang J, Perez-Moreno P, Button P, Gregory D, Mok TS. 1223OASPIRATION: FIRST-LINE ERLOTINIB (E) UNTIL AND BEYOND RECIST PROGRESSION (PD) IN ASIAN PATIENTS (PTS) WITH EGFR MUTATION-POSITIVE (MUT+) NSCLC. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 25: iv426-iv427. PMID 28171262 DOI: 10.1093/annonc/mdu349.2  0.52
2014 Woo JM, Park EJ, Lee M, Ahn M, Kwon S, Koo KH. Changes in attitudes toward and patterns in traditional Korean medicine among the general population in South Korea: a comparison between 2008 and 2011. Bmc Complementary and Alternative Medicine. 14: 436. PMID 25380563 DOI: 10.1186/1472-6882-14-436  0.6
2011 Sun J, Ahn JS, Park K, Han JH, Ahn M. Significance of thymidylate synthase and thyroid transcription factor 1 expression in patients with nonsquamous non-small cell lung cancer treated with pemetrexed-based chemotherapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 7579. PMID 28023130 DOI: 10.1200/jco.2011.29.15_suppl.7579  0.52
2011 Tan E, Park K, Lim WT, Ahn M, Ng QS, Ahn JS, Tan DS, Sun J, Jac J, Han M, Payumo FC, Credi M, McKee K, Cotreau MM, Bhargava P, et al. Phase Ib study of ficlatuzumab (formerly AV-299), an anti-hepatocyte growth factor (HGF) monoclonal antibody (MAb) in combination with gefitinib (G) in Asian patients (pts) with NSCLC. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 7571. PMID 28023115 DOI: 10.1200/jco.2011.29.15_suppl.7571  0.52
2011 Hoe N, Park K, Um S, Liu X, Kim PS, Kirkland R, Lee TA, Zhou J, Nguyen A, Ma Y, Ahn M, Singh S. Selection of targeted agent(s) based on matching differential protein expression and mutational profile in NSCLC patients. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: e21085. PMID 28022228 DOI: 10.1200/jco.2011.29.15_suppl.e21085  0.52
2011 Yi SY, Ahn M, Park JY, Lee HR, Lee J, Park YH, Ahn JS, Park K. Prognostic factors in elderly patients with advanced non-small cell lung cancer treated with platinum-based doublet chemotherapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: e19584. PMID 28021053 DOI: 10.1200/jco.2011.29.15_suppl.e19584  0.6
2011 Ahn HK, Choi YL, Sun J, Ahn YC, Kim K, Kim J, Shim YM, Ahn JS, Park K, Ahn M. The association of epidermal growth factor receptor (EGFR) mutation and survival in N2(+) non-small cell lung cancer patients treated with platinum-based neoadjuvant concurrent chemoradiotherapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 7034. PMID 28020054 DOI: 10.1200/jco.2011.29.15_suppl.7034  0.52
2009 Kim K, Lee J, Chang M, Uhm J, Yun JA, Yi S, Park Y, Ahn J, Park K, Ahn M. Primary chemotherapy, stereotactic radiosurgery, or whole brain radiotherapy in non-small cell lung cancer (NSCLC) patients with asymptomatic brain metastases. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: e19063. PMID 27962138 DOI: 10.1200/jco.2009.27.15_suppl.e19063  0.52
2009 Jun H, Chang M, Ko Y, Ahn Y, Jeong H, Son Y, Baek J, Park Y, Park K, Ahn M. Clinical significance of type 1 insulin-like growth factor receptor and insulin-like growth factor binding protein-3 expression in squamous cell carcinoma of head and neck. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 6036. PMID 27961911 DOI: 10.1200/jco.2009.27.15_suppl.6036  0.52
2009 Choi J, Ahn M, Park Y, Oh Y, Park K, Jeong H, Son Y, Baek C, Ahn Y. EZH2 expression and correlation with Ki-67 and p53 in head and neck squamous cell carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: e17018. PMID 27961709 DOI: 10.1200/jco.2009.27.15_suppl.e17018  0.52
2009 Kim HS, Park K, Ahn MJ, Park Y, Lee S, Baek C, Son Y, Jeong H, Ahn Y, Park B. Concurrent chemoradiotherapy with weekly docetaxel and cisplatin for locally advanced head and neck cancer: Phase I study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: e17026. PMID 27961697 DOI: 10.1200/jco.2009.27.15_suppl.e17026  0.52
2005 Ha JW, Kang SM, Pyun WB, Lee JY, Ahn MY, Kang WC, Jeon TJ, Chung N, Lee JD, Cho SH. Serial assessment of myocardial properties using cyclic variation of integrated backscatter in an adriamycin-induced cardiomyopathy rat model. Yonsei Medical Journal. 46: 73-7. PMID 15744808 DOI: 10.3349/ymj.2005.46.1.73  0.44
Show low-probability matches.